4 completed. 2 Early Phase 1, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 2 |
| Phase 1 | 2 | Completed 2 |
Follow Harmine: new trials by email Literature Review of Harmine trials Research Report on Harmine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Molecular Imaging Study of Harmine/DMT: a Basic Research Approach N,N-dimethyltryptamine (DMT) + harmine, Placebo - Neuropharmacological Investigation of Ayahuasca Constituents DMT and Harmine | Phase 1 | Completed | Insel Gruppe AG, University Hospital Bern | 17 | 2024-01-22 | 2025-03-19 |
| Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects Dimethyltryptamin (DMT) & Harmine - Healthy | Phase 1 | Completed | Reconnect Labs | 16 | 2023-05-05 | 2023-11-02 |
| Mindfulness and Psychedelics DMT + harmine, Placebo - Healthy Participants | Early Phase 1 | Completed | Milan Scheidegger | 40 | 2023-02-20 | 2023-09-21 |
| Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects DMT, Harmine, Placebo (Harmine) - Emotions, Mood | Early Phase 1 | Completed | Psychiatric University Hospital, Zurich | 34 | 2020-12-01 | 2022-10-04 |
Insel Gruppe AG, University Hospital Bern (1) · Milan Scheidegger (1) · Psychiatric University Hospital, Zurich (1) · Reconnect Labs (1)
Switzerland (4)
Erich Seifritz, Prof (1) · Milan Scheidegger, MD, PhD (1) · Paul K Cumming, PhD (1)
PMID 38089057, PMID 39340164, PMID 39774840, PMID 40484114, PMID 42220002, PMID 42768932
2018 (1)